Saturday’s Daily Piece: New Option for Treating Severe Hypoglycemia

Hypoglycemia is serious business. Timely treatment is essential. We now have an additional option for treatment of hypoglycemia. Dasiglucagon (brand name Zegalogue) is a human glucagon analogue that is approved for treatment of severe hypoglycemia in persons with diabetes 6 years of age and older. The three studies assessing efficacy of dasiglucagon included children 6 – 17 years old and adults with type 1 diabetes. On average, the median time to glucose recovery was 10 minutes across the three studies. To learn more about this new option for treatment of hypoglycemia, please click below.

A leader in treating specialty gastrointestinal and metabolic diseases
This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#dasiglucagon #hypoglycemia #treatment

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.